Fusion of CTLA-4 with HPV16 E7 and E6 Enhanced the Potency of Therapeutic HPV DNA Vaccine

Neutrophils mediate antibody-induced antitumor effects in mice

(2013) M. Albanesi et al.   BLOOD

Clinical trials of human papillomavirus vaccines and beyond

(2013) Matti Lehtinen et al.   Nature Reviews Clinical Oncology

Comprehensive Control of Human Papillomavirus Infections and Related Diseases

(2013) F. Xavier Bosch et al.   VACCINE

Combination strategies to enhance antitumor ADCC

(2012) Holbrook E Kohrt et al.   Immunotherapy

The effect of antigen size on the immunogenicity of antigen presenting cell targeted DNA vaccine

(2011) Rong Jia et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Clinical Cancer Therapy by NK Cells via Antibody-Dependent Cell-Mediated Cytotoxicity

(2011) Kory L. Alderson et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

(2011) Anna R. Giuliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

DNA Immunization with Fusion of CTLA-4 to Hepatitis B Virus (HBV) Core Protein Enhanced Th2 Type Responses and Cleared HBV with an Accelerated Kinetic

(2011) Ying Yin et al.   PLoS One

HPV-associated head and neck cancer: a virus-related cancer epidemic

(2010) Shanthi Marur et al.   LANCET ONCOLOGY

Therapeutic HPV DNA vaccines

(2009) Archana Monie et al.   Expert Review of Vaccines

A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3

(2008) C. L. Trimble et al.   CLINICAL CANCER RESEARCH

Enhancement of immunotherapeutic effects of HPV16E7 on cervical cancer by fusion with CTLA4 extracellular region

(2008) Yi Zheng et al.   JOURNAL OF MICROBIOLOGY

The human papillomavirus E7 oncoprotein

(2008) Margaret E. McLaughlin-Drubin et al.   VIROLOGY

Human papillomavirus in cervical and head-and-neck cancer

(2007) Amanda Psyrri et al.   Nature clinical practice. Oncology